Profile for Turkey Patent: 201908082
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Turkey Patent: 201908082
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 8,329,648 | Feb 18, 2027 | Astrazeneca Ab | BYDUREON | exenatide synthetic |
| 8,329,648 | Feb 18, 2027 | Astrazeneca Ab | BYDUREON PEN | exenatide synthetic |
| 8,329,648 | Feb 18, 2027 | Astrazeneca Ab | BYDUREON BCISE | exenatide synthetic |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
